Clinoscope buys 40 million Neimeth shares for N312 million after 2025 sell-off

Clinoscope Services Limited, a major institutional shareholder in Neimeth International Pharmaceuticals Plc, acquired an additional 40 million ordinary shares valued at N312 million. The transaction follows a sell-off in Neimeth shares during 2025 and represents a disclosed corporate action involving the listed healthcare company.